 WALTHAM, Mass., June 03, 2022 GLOBE NEWSWIRE -- Dyne Therapeutics, Inc. Nasdaq: DYN, a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference being held in New York, NY on Thursday, June 9, 2022 at 3:00 p.m. ET. 